Krsnaa Diagnostics (KRSNAA) Stock Overview
Provides diagnostic services in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
KRSNAA Community Fair Values
Create NarrativeSee what 30 others think this stock is worth. Follow their fair value or set your own to get alerts.
Krsnaa Diagnostics Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹599.65 |
| 52 Week High | ₹894.40 |
| 52 Week Low | ₹579.15 |
| Beta | -0.24 |
| 1 Month Change | -10.32% |
| 3 Month Change | -19.24% |
| 1 Year Change | -16.22% |
| 3 Year Change | 50.70% |
| 5 Year Change | n/a |
| Change since IPO | -39.25% |
Recent News & Updates
Recent updates
Krsnaa Diagnostics Limited Just Missed EPS By 23%: Here's What Analysts Think Will Happen Next
Feb 08
Are Investors Undervaluing Krsnaa Diagnostics Limited (NSE:KRSNAA) By 50%?
Nov 15Returns At Krsnaa Diagnostics (NSE:KRSNAA) Are On The Way Up
Sep 30Krsnaa Diagnostics (NSE:KRSNAA) Is Increasing Its Dividend To ₹2.75
Sep 04Krsnaa Diagnostics' (NSE:KRSNAA) Dividend Will Be Increased To ₹2.75
Aug 14Krsnaa Diagnostics Limited (NSE:KRSNAA) Stocks Shoot Up 26% But Its P/E Still Looks Reasonable
Jul 18Earnings Miss: Krsnaa Diagnostics Limited Missed EPS By 7.7% And Analysts Are Revising Their Forecasts
May 17There's Been No Shortage Of Growth Recently For Krsnaa Diagnostics' (NSE:KRSNAA) Returns On Capital
Mar 21Krsnaa Diagnostics Limited Just Missed Earnings - But Analysts Have Updated Their Models
Feb 17
Expansion Into Underpenetrated Markets Will Increase Access To Advanced Diagnostic Services
Expansion into Tier 2 and 3 cities and strategic partnerships in healthcare sectors are expected to drive revenue growth and improve profit margins.After Leaping 30% Krsnaa Diagnostics Limited (NSE:KRSNAA) Shares Are Not Flying Under The Radar
Nov 26Krsnaa Diagnostics' (NSE:KRSNAA) Dividend Is Being Reduced To ₹2.50
Sep 06Krsnaa Diagnostics (NSE:KRSNAA) Has Announced That Its Dividend Will Be Reduced To ₹2.50
Aug 23Krsnaa Diagnostics Limited (NSE:KRSNAA) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Aug 10Krsnaa Diagnostics' (NSE:KRSNAA) Dividend Is Being Reduced To ₹2.50
Aug 09Krsnaa Diagnostics Limited's (NSE:KRSNAA) 28% Jump Shows Its Popularity With Investors
Jul 05Here's What To Make Of Krsnaa Diagnostics' (NSE:KRSNAA) Decelerating Rates Of Return
Jun 16We Think That There Are More Issues For Krsnaa Diagnostics (NSE:KRSNAA) Than Just Sluggish Earnings
May 26Is Krsnaa Diagnostics (NSE:KRSNAA) A Risky Investment?
Mar 14Krsnaa Diagnostics Limited Just Missed Earnings - But Analysts Have Updated Their Models
Feb 16Krsnaa Diagnostics (NSE:KRSNAA) Will Pay A Larger Dividend Than Last Year At ₹2.75
Aug 31Krsnaa Diagnostics (NSE:KRSNAA) Will Pay A Larger Dividend Than Last Year At ₹2.75
Aug 17Returns On Capital Are Showing Encouraging Signs At Krsnaa Diagnostics (NSE:KRSNAA)
Jun 03Revenue Miss: Krsnaa Diagnostics Limited Fell 6.4% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Feb 17Take Care Before Diving Into The Deep End On Krsnaa Diagnostics Limited (NSE:KRSNAA)
Feb 16Krsnaa Diagnostics' (NSE:KRSNAA) Anemic Earnings Might Be Worse Than You Think
Nov 17Shareholder Returns
| KRSNAA | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | 2.0% | -3.8% | -4.4% |
| 1Y | -16.2% | 12.2% | 4.9% |
Return vs Industry: KRSNAA underperformed the Indian Healthcare industry which returned 12.2% over the past year.
Return vs Market: KRSNAA underperformed the Indian Market which returned 4.9% over the past year.
Price Volatility
| KRSNAA volatility | |
|---|---|
| KRSNAA Average Weekly Movement | 3.8% |
| Healthcare Industry Average Movement | 5.4% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 3.9% |
Stable Share Price: KRSNAA has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: KRSNAA's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 3,471 | Mitesh Dave | krsnaadiagnostics.com |
Krsnaa Diagnostics Limited provides diagnostic services in India. It offers a range radiology services, including computed tomography scans, magnetic resonance imaging, X-rays, and ultrasound and advanced imaging; pathology services, such as laboratory, and home collection and preventive health; and teleradiology and telepathology services. The company also provides other diagnostics services, such as ophthalmic test, mammography, dental imaging, stress test, dual-energy X-ray absorptiometry scan, and bone mineral density test.
Krsnaa Diagnostics Limited Fundamentals Summary
| KRSNAA fundamental statistics | |
|---|---|
| Market cap | ₹19.45b |
| Earnings (TTM) | ₹803.87m |
| Revenue (TTM) | ₹7.66b |
Is KRSNAA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| KRSNAA income statement (TTM) | |
|---|---|
| Revenue | ₹7.66b |
| Cost of Revenue | ₹1.80b |
| Gross Profit | ₹5.87b |
| Other Expenses | ₹5.06b |
| Earnings | ₹803.87m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
May 30, 2026
| Earnings per share (EPS) | 24.78 |
| Gross Margin | 76.56% |
| Net Profit Margin | 10.49% |
| Debt/Equity Ratio | 31.0% |
How did KRSNAA perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/16 04:32 |
| End of Day Share Price | 2026/03/16 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Krsnaa Diagnostics Limited is covered by 6 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hrishikesh Patole | Batlivala & Karani Securities India Pvt. Ltd. |
| Bharat Celly | Equirus Securities Private Limited |
| null null | Equirus Securities Private Limited |